# FDA WARNING_LETTER - Oregon Health & Science University - May 12, 2010

Source: https://www.keypedia.com/records/warning_letter/oregon-health-science-university/1ebf3360-af7c-4a74-bf31-67dae4671dd7

> FDA WARNING_LETTER for Oregon Health & Science University on May 12, 2010. Product: Biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: WARNING_LETTER
- Company Name: Oregon Health & Science University
- Inspection Date: 2010-05-12
- Product Type: Biologics
- Office Name: Seattle District Office
- Summary: The FDA conducted inspections of Oregon Health & Science University's Special Immunology and Coagulation Laboratory (SIC) from April 20-28, 2010, and Pacific Northwest Transplant Bank (PNTB) from April 28-May 12, 2010. The SIC laboratory was found to have significant deviations from 21 CFR Part 1271 for human cells, tissues, and cellular and tissue-based products (HCT/Ps).

A primary violation was the failure to use appropriate FDA-licensed, approved, or cleared donor screening tests in accordance with manufacturer's instructions [21 CFR 1271.80(c)]. Specifically, between August 3 and September 3, 2008, SIC used an expired Hepatitis B Virus Core Antigen EIA screening test (expired July 29, 2008) for six HCT/P donors. Between February 9 and February 24, 2010, SIC used an expired Hepatitis C Virus Encoded Antigen EIA screening test (expired January 12, 2010) for five HCT/P donors. PNTB confirmed that results from these expired tests were used for donor eligibility determinations, and HCT/Ps from these donors were distributed.

The FDA acknowledged a May 6, 2010, response from OHSU, but deemed it inadequate.

## Related Officers

- [District Director](https://www.keypedia.com/people/charles-m-breen/ea1c624f-6943-4e12-b826-4cffbf358220)

Company: https://www.keypedia.com/companies/oregon-health-science-university/f5f2d429-c9f4-44d5-a315-6a301297885e

Office: https://www.keypedia.com/offices/seattle-district-office/9305837f-0738-4075-b444-a55e7a2b8913